Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 10:34 AM ISTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis Farhat Nasim26 April 2019 12:49 PM ISTLeflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis Farhat Nasim6 April 2019 3:00 PM ISTTofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing. New...
FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart Medical Dialogues Bureau18 Sept 2018 12:47 PM ISTSupreme court lifted the ban on the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, banned...
Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 10:15 AM ISTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
